These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5697093)

  • 21. Chromosomal effect in vivo of exposure to lysergic acid diethylamide.
    Sparkes RS; Melnyk J; Bozzetti LP
    Science; 1968 Jun; 160(3834):1343-5. PubMed ID: 5651893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides.
    Mallaroni P; Mason NL; Vinckenbosch FRJ; Ramaekers JG
    Psychopharmacology (Berl); 2022 Jun; 239(6):1783-1796. PubMed ID: 35487983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
    McKenna DJ; Saavedra JM
    Eur J Pharmacol; 1987 Oct; 142(2):313-5. PubMed ID: 3691644
    [No Abstract]   [Full Text] [Related]  

  • 24. Steric and electronic relationships among some hallucinogenic compounds.
    Kang S; Green JP
    Proc Natl Acad Sci U S A; 1970 Sep; 67(1):62-7. PubMed ID: 5272329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of tryptamine and lysergic acid diethylamide (LSD) on cutaneous C-fiber and polysynaptic reflexes in the cat.
    Bell JA; Martin WR
    J Pharmacol Exp Ther; 1974 Sep; 190(3):492-500. PubMed ID: 4607113
    [No Abstract]   [Full Text] [Related]  

  • 26. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 28. Cross tolerance to tryptamine in the LSD tolerant dog.
    Martin WR; Eades CG
    Psychopharmacologia; 1972; 27(2):93-8. PubMed ID: 4638212
    [No Abstract]   [Full Text] [Related]  

  • 29. Tryptamine in the brain and spinal cord: its role in the LSD response.
    Martin WR; Sloan JW; Vaupel DB
    Psychopharmacol Bull; 1976 Oct; 12(4):31-2. PubMed ID: 972983
    [No Abstract]   [Full Text] [Related]  

  • 30. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrochemistry and analytical determination of lysergic acid diethylamide (LSD) via adsorptive stripping voltammetry.
    Merli D; Zamboni D; Protti S; Pesavento M; Profumo A
    Talanta; 2014 Dec; 130():456-61. PubMed ID: 25159435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].
    FERNANDEZ-CERDENO A; LEUNER H
    Z Psychosom Med; 1965; 11():45-54. PubMed ID: 14301325
    [No Abstract]   [Full Text] [Related]  

  • 33. [Modern treatments in psychiatry. Hallucinogens: psychosis induced by LSD].
    JOST F; GEERTZ VW
    Folia Clin Int (Barc); 1961 Sep; 11():440-5 contd. PubMed ID: 14452572
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of the effects of LSD-25, d-amphetamine and tryptamine on electrically evoked responses in the visual system by methiothepin and octoclothepin.
    Moore RH; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):66-73. PubMed ID: 581833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
    Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
    Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M; Johansen SS; Thomsen R; Linnet K
    Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
    Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
    J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
    Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
    J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [REVIEW OF PSYCHODYSLEPTICS: I. CLASSIFICATION OF PSYCHODYSLEPTICS].
    RAJOTTE P
    Can Med Assoc J; 1964 Aug; 91(6):293-300. PubMed ID: 14184040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.